
Age-Related Dermoscopic Features: A Key to Early Melanoma Detection
Understanding age-related dermoscopic features is essential for clinicians managing high-risk patients. A recent study involving 832 individuals highlights how the appearance of melanomas and nevi varies significantly across different stages of life. By recognizing these age-specific patterns, dermatologists can improve diagnostic accuracy and optimize surgical decision-making. This explorative study analyzed over 1,700 excised lesions to identify signatures that separate benign nevi from malignant growths.
The Role of Monitoring in High-Risk Patients
The study monitored patients using total body photography (TBP) and sequential digital dermoscopy (SDD). These tools allow for the detection of subtle changes over time. Interestingly, the researchers found that 10.7% of the excised lesions were confirmed as melanomas. Because the risk of malignancy increases with age, understanding static and dynamic patterns becomes vital. Furthermore, the study categorized participants into three distinct age brackets: under 30, 30 to 50, and over 50 years.
Key Age-Related Dermoscopic Features in Melanoma
Each age group displayed unique \"signature\" features. For instance, in patients under 30 (Group I), melanomas often presented with a blue-whitish veil and symmetrical enlargement without globules. In contrast, those aged 30 to 50 (Group II) frequently showed irregular pigmentation and irregular dots or globules. Finally, the oldest group (Group III) exhibited regression structures and atypical pigment networks. Additionally, this group often showed an atypical vascular pattern. Consequently, these findings suggest that a one-size-fits-all approach to dermoscopy may overlook critical signs in older populations.
Differentiating Nevi Across the Lifespan
Distinguishing nevi from melanoma requires a deep understanding of benign evolution. In the youngest group, nevi typically showed symmetrical enlargement with globules. However, in patients over 50, nevi frequently showed no enlargement at all. Therefore, a growing lesion in an older patient should always raise clinical suspicion. Specifically, the appearance of new structures or irregular patterns in older skin warrants immediate investigation. Moreover, clinicians should remain vigilant when monitoring patients with high nevus counts.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
- Burghaus-Zhang J et al. Age-related dermatoscopic features of excised melanomas versus nevi in 832 high risk patients. J Dtsch Dermatol Ges. 2026 May 18. doi: 10.1111/ddg.70243. PMID: 42145200.
- Slowinska M, et al. Clinical, Dermoscopic, and Histological Characteristics of Melanoma Patients According to the Age Groups. MDPI. 2023.
- Zalaudek I, et al. Dermoscopy of Melanoma According to Age Groups: A Retrospective Monocentric Study. NIH. 2025.
Frequently Asked Questions
How do dermoscopic patterns of melanoma change with age?
Patterns evolve from symmetrical enlargement in younger patients to irregular pigmentation and regression structures in older individuals. Older patients often show atypical pigment networks and vascular patterns.
Why is sequential digital dermoscopy important?
It allows clinicians to track dynamic changes in lesions. For example, recognizing that nevi in older adults rarely enlarge helps identify suspicious growth that might indicate melanoma.
"
More from MedShots Daily

A study of 832 high-risk patients reveals unique age-related dermoscopic patterns that help differentiate melanomas from nevi across various life stages....
3 days back

A global survey reveals that despite high treatment compliance, many haemophilia patients still suffer from joint issues and frequent bleeding episodes....
Today

A new study reveals that disclosing Breast Cancer Polygenic Risk Scores significantly reduces decisional conflict for women with BRCA1/2 variants....
Today

Procizumab is a humanized antibody that neutralizes circulating DPP3, a biological driver of shock, by preventing angiotensin II degradation....
Today

Medtronic has announced its plans to acquire SPR Therapeutics for $650 million, expanding its non-opioid, minimally invasive chronic pain treatments....
Today

Research highlights sex-specific roles of oxytocin neurons in the hypothalamus and signaling in the nucleus accumbens regarding juvenile social play behavio...
Today